Prestrelski Steven
Chief Scientific Officer at XERS; Chief Scientific Officer at XERIS PHARMACEUTICALS INC
- Sold, on record
- $917k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Feb 22, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- XERSXeris Biopharma Holdings, Inc.Chief Scientific Officer
- XERIS PHARMACEUTICALS INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- XERIS PHARMACEUTICALS INC95,720 shares
- XERS11,228 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedJan 11, 2019 2019
Sold 2,300 shares
Prestrelski Steven, Chief Scientific Officer
Sold 0.5% of holdings487,024 shares leftFiling
- 2 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedApr 11, 2019 +90 days
Sold 10,000 shares at $9.56 ($96k)
Prestrelski Steven, Chief Scientific Officer
Sold 2.1% of holdings ($4.7M position)477,024 shares leftFiling
- 3 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedOct 11, 2019 +183 days
Sold 27,700 shares at $12.01 ($333k)
Prestrelski Steven, Chief Scientific Officer
Sold 5.8% of holdings ($5.7M position)449,324 shares leftFiling
- 4 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedJan 13, 2020 +94 days
Sold 10,000 shares at $5.50 ($55k)
Prestrelski Steven, Chief Scientific Officer
Sold 2.3% of holdings ($2.4M position)421,824 shares left0.8x usual sizeFiling
- 5 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedJan 11, 2021 +364 days
Sold 10,000 shares at $5.72 ($57k)
Prestrelski Steven, Chief Scientific Officer
Sold 2.3% of holdings ($2.4M position)416,824 shares left1x usual sizeFiling
- 6 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedJan 13, 2021 +2 days
Sold 10,000 shares at $6.01 ($60k)
Prestrelski Steven, Chief Scientific Officer
Sold 2.4% of holdings ($2.5M position)406,824 shares left1x usual sizeFiling
- 7 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedApr 12, 2021 +89 days
Sold 10,000 shares at $4.07 ($41k)
Prestrelski Steven, Chief Scientific Officer
Sold 2% of holdings ($2.1M position)496,824 shares left1x usual sizeFiling
- 8 Form 4 sale XERSPlan not statedFeb 22, 2022 +316 days
Sold 11,228 shares at $2.42 ($27k)
Prestrelski Steven, Chief Scientific Officer
Sold 1.9% of holdings ($1.4M position)569,780 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Feb 24, 2022 | XERS | Chief Scientific Officer | Form 4 sale | 11,228 | $27k | 1.9% | Plan not stated | SEC |
| Apr 12, 2021 | Apr 13, 2021 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $41k | 2.0% | Plan not stated | SEC |
| Jan 13, 2021 | Jan 15, 2021 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $60k | 2.4% | Plan not stated | SEC |
| Jan 11, 2021 | Jan 12, 2021 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $57k | 2.3% | Plan not stated | SEC |
| Jan 13, 2020 | Jan 14, 2020 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $55k | 2.3% | Plan not stated | SEC |
| Oct 11, 2019 | Oct 16, 2019 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 27,700 | $333k | 5.8% | Plan not stated | SEC |
| Apr 11, 2019 | Apr 12, 2019 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $96k | 2.1% | Plan not stated | SEC |
| Jan 11, 2019 | Jan 15, 2019 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 2,300 | 0.5% | Plan not stated | SEC | |
| Dec 26, 2018 | Jan 2, 2019 | XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 15,720 | $249k | 3.1% | Plan not stated | SEC |